IgA Nephropathy: The Presence of Familial Disease Does Not Confer an Increased Risk for Progression

American Journal of Kidney Diseases

Volumn 47, Issue 5, 2006, Pages 761-769

  Izzi, Claudia ^{a,b,c,d,e,f,g,h}   Ravani, Pietro ^{a,b,c,d,e,f,g,h}   Torres, Diletta ^{a,b,c,d,e,f,g,h}   Prati, Elisabetta ^{a,b,c,d,e,f,g,h}   Viola, Battista Fabio ^{a,b,c,d,e,f,g,h}   Guerini, Simona ^{a,b,c,d,e,f,g,h}   Foramitti, Marina ^{a,b,c,d,e,f,g,h}   Frascà, Giovanni ^{a,b,c,d,e,f,g,h}   Amoroso, Antonio ^{a,b,c,d,e,f,g,h}   Ghiggeri, Gian Marco ^{a,b,c,d,e,f,g,h}   Schena, Francesco Paolo ^{a,b,c,d,e,f,g,h}   Scolari, Francesco ^{a,b,c,d,e,f,g,h}  

^a SPEDALI CIVILI   (Italy)

^b CREMONA HOSPITAL   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d Ospedale di Desenzano   (Italy)

^e Ospedale di Ancona   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g G GASLINI INSTITUTE   (Italy)

^h MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Familial immunoglobulin A (IgA) nephropathy; glomerular filtration rate; renal survival; risk factors; sporadic immunoglobulin A (IgA) nephropathy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STEROID;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FAMILIAL DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; HEMATURIA; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PROGNOSIS; PROTEINURIA; REGRESSION ANALYSIS; SEX DIFFERENCE; SURVIVAL RATE;

ADULT; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PHENOTYPE; RISK FACTORS; SURVIVAL RATE;

EID: 33646064092     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.01.010     Document Type: Article

References (31)

1. Berger J., and Hinglais N. Les depots intercapillaires d'IgA-IgG. J Urol Nephrol (Paris) 74 (1968) 694-695
2. D'Amico G. The commonest glomerulonephritis in the world. IgA nephropathy. Q J Med 245 (1987) 709-727
3. Donadio J.V., and Grande J.P. IgA nephropathy. N Engl J Med 347 (2002) 738-748
4. Floege J., and Feehally J. IgA nephropathy. Recent developments. J Am Soc Nephrol 11 (2000) 2395-2403
5. D'Amico G. Natural history of idiopathic IgA nephropathy. Role of clinical and histological prognostic factors. Am J Kidney Dis 36 (2000) 227-237
6. Radford Jr. M.G., Donadio Jr. J.V., Bergstralh E.J., and Grande J.P. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 8 (1997) 199-207
7. Ibels L.S., and Gyory A.Z. IgA nephropathy. Analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine 73 (1994) 79-102
8. Johnston P.A., Brown J.S., Braumholtz D.A., and Davison A.M. Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC Glomerulonephritis Registry. Q J Med 84 (1992) 619-627
9. Alamartine E., Sabatier J.-C., Guerin C., Berliet J.-M., and Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis. An extensive study with univariate and multivariate analyses. Am J Kidney Dis 18 (1991) 12-19
10. Katafuchi R., Oh Y., Hori K., et al. An important role of glomerular segmental lesions on progression of IgA nephropathy. A multivariate analysis. Clin Nephrol 41 (1994) 191-198
11. Bartosik L.P., Lajoie G., Sugar L., and Cattran D.C. Predicting progression in IgA nephropathy. Am J Kidney Dis 38 (2001) 728-735
12. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 24 (2004) 179-196
13. Julian B., and Novak J. IgA nephropathy. An update. Curr Opin Nephrol Hypertens 13 (2004) 171-179
14. Hsu S.I., Ramirez S.B., Winn M.P., Bonventre J.V., and Owen W.F. Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 57 (2000) 1818-1835
15. Gharavi A.G., Yan Y., Scolari F., et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 26 (2000) 354-357
16. Levy M. Multiplex families in IgA nephropathy. Contrib Nephrol 104 (1993) 46-53
17. Scolari F. Inherited forms of IgA nephropathy. J Nephrol 16 (2003) 317-320
18. Scolari F., Amoroso A., Savoldi S., et al. Familial clustering of IgA nephropathy. Further evidence in an Italian population. Am J Kidney Dis 33 (1999) 857-865
19. Julian B.A., Woodford S.Y., Baehler R.W., McMorrow R.G., and Wyatt R.J. Familial clustering and immunogenetic aspects of IgA nephropathy. Am J Kidney Dis 12 (1988) 366-370
20. Schena F.P., Cerullo G., Rossini M., Lanzilotta S.G., D'Altri G., and Manno C. Increased risk of end-stage renal disease in familial IgA nephropathy. J Am Soc Nephrol 13 (2002) 453-460
21. Levey A.S., Greene T.G., Kusek J.W., and Beck G.L. Modification of Diet in Renal Disease Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 0828A (abstr)
22. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. Evaluation, classification, and stratification. Part 4. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis 39 suppl 2 (2002) S46-S75
23. Churg J., and Sobin L.H. IgA nephropathy. Renal Disease. Classification and Atlas of Glomerular Disease (1982), Igaku-Shoin, Tokyo, Japan
24. Hosmer D.W., and Lemeshow L.S. Other models and topics. Applied Survival Analysis, Regression Modelling of Time to Event Data (1999), Wiley, New York, NY 312-313
25. Geddes C., Rauta V., Gronhagen-Riska C., et al. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 18 (2003) 1541-1548
26. Kanno Y., Okada H., Yamaji Y., Nakazato Y., and Suzuki H. Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation. Q J Med 98 (2005) 199-203
27. Nakao N., Yoshimura A., Morita H., Takada M., Kayano T., and Ideura T. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE). A randomised controlled trial. Lancet 361 (2003) 117-124
28. Pozzi C., Bolasco P.G., Fogazzi G.B., et al. Corticosteroids in IgA nephropathy. A randomised controlled trial. Lancet 353 (1999) 883-887
29. Bonnet F., Deprele C., Sassolas A., et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 37 (2001) 720-727
30. Orth S.R., Stockmann A., Conradt C., et al. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 54 (1998) 926-931
31. Tonelli M., Sacks F., Pfeffer M., Jhangri G., and Curhan G. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68 (2005) 237-145